Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1962 1
1965 1
1969 2
1970 2
1972 1
1973 1
1974 3
1975 2
1976 1
1977 3
1979 3
1980 3
1981 2
1982 3
1983 2
1984 6
1985 2
1986 1
1987 3
1988 3
1989 3
1990 2
1991 2
1992 2
1993 1
1994 5
1995 5
1996 6
1997 2
1998 4
1999 4
2000 4
2001 5
2002 4
2003 2
2004 8
2005 7
2006 2
2007 2
2008 4
2009 2
2012 4
2013 3
2014 4
2015 6
2016 5
2017 5
2018 4
2019 5
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Results by year
Filters applied: . Clear all
Page 1
AAV: An Overview of Unanswered Questions.
Berns KI, Muzyczka N. Berns KI, et al. Hum Gene Ther. 2017 Apr;28(4):308-313. doi: 10.1089/hum.2017.048. Hum Gene Ther. 2017. PMID: 28335618 Free PMC article. Review.
Gene therapy using adeno-associated virus vectors.
Daya S, Berns KI. Daya S, et al. Among authors: berns ki. Clin Microbiol Rev. 2008 Oct;21(4):583-93. doi: 10.1128/CMR.00008-08. Clin Microbiol Rev. 2008. PMID: 18854481 Free PMC article. Review.
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors.
Berns K, Caumanns JJ, Hijmans EM, Gennissen AMC, Severson TM, Evers B, Wisman GBA, Jan Meersma G, Lieftink C, Beijersbergen RL, Itamochi H, van der Zee AGJ, de Jong S, Bernards R. Berns K, et al. Oncogene. 2018 Aug;37(33):4611-4625. doi: 10.1038/s41388-018-0300-6. Epub 2018 May 15. Oncogene. 2018. PMID: 29760405 Free PMC article.
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K, Linn SC, Gonzalez-Angulo AM, Stemke-Hale K, Hauptmann M, Beijersbergen RL, Mills GB, van de Vijver MJ, Bernards R. Berns K, et al. Cancer Cell. 2007 Oct;12(4):395-402. doi: 10.1016/j.ccr.2007.08.030. Cancer Cell. 2007. PMID: 17936563 Free article. Clinical Trial.
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.
Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, Symmans WF, Pusztai L, Nolden LK, Horlings H, Berns K, Hung MC, van de Vijver MJ, Valero V, Gray JW, Bernards R, Mills GB, Hennessy BT. Stemke-Hale K, et al. Among authors: berns k. Cancer Res. 2008 Aug 1;68(15):6084-91. doi: 10.1158/0008-5472.CAN-07-6854. Cancer Res. 2008. PMID: 18676830 Free PMC article.
161 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page